Hepatitis C and Renal Disease
Lister Hill Auditorium
Bethesda, Md.
October 21-22, 2002
Summary
Hepatitis C, the most common cause of chronic liver disease in the United States, is particularly common in the chronic renal disease patient population. As hepatitis C is most effectively transmitted by percutaneous exposure to infected blood, patients with chronic renal disease are at high risk for acquiring the disease from transfusion of blood products or from parenteral exposure to hepatitis C virus infection during hemodialysis treatments. It is noteworthy that in addition to its frequent occurrence in patients with pre-existing chronic renal disease, hepatitis C can induce an inflammatory glomerular lesion in some infected patients without pre-existing renal disease, which may cause chronic renal impairment. Patients with hepatitis C and renal disease may develop serious and progressive chronic liver disease, with its associated long-term morbidity and mortality from cirrhosis.
Agenda
Day 1: Monday, October 21, 2002
8:30 am – 5:30 pm
Session 1: Hepatitis C
Miriam Alter and Josephine Briggs
Hepatitis C Virus, Marian Major
Course and Outcome of Hepatitis C, Leonard Seeff
Current Therapy of Hepatitis C, Charles Howell
Session 2: HCV–Related Glomerular Disease Catherine Stehman-Breen and Michael Fried
Epidemiology of HCV– Related Renal Disease, Paul Eggers
Cryoglobulinemia and HCV Infection, Vincent Agnello
Spectrum of HCV–Related Glomerular Disease, Charles Alpers
Therapy of HCV–Related Renal Disease, Giuseppe D' Amico
Session 3: Hepatitis C and End-Stage Renal Disease Brian Pereira and Mitchell Shiffman
Epidemiology of Hepatitis C in Dialysis Units, Miriam Alter
Hepatitis C in Dialysis Patients, Brian Pereira
Spectrum of Hepatitis C in Dialysis Patients, Paul Martin
Session 4: Hepatitis C and End-Stage Renal Disease – TherapyEmmet Keeffe and Michel Jadoul
Therapy of Hepatitis C in ESRD, Stansilas Pol
Pharmacokinetics of Peginterferon in Renal Disease, S.Chris Pappas
Peginterferon Therapy of Hepatitis C in ESRD, Mark Russo
Ribavirin and Peginterferon for Hepatitis C in ESRD, Bruce Luxon
Day 2: Tuesday, October 22, 2002
8:30 am – 12:30 pm
Session 5: Hepatitis C and Renal Transplantation
Jeffrey Kopp and Paul Martin
Natural History of Hepatitis C After Renal Transplantation, David Roth
Renal Transplantation Issues in HCV-infected Donors and Recipients, Svetlozar Natov
HCV-Related Renal Disease After Renal Transplantation, John Pirsch
HCV-Related Renal Disease After Liver Transplantation, Raymond Chung
Therapy of Hepatitis C After Renal Transplantation, Lionel Rostaing
Session 6: Meeting Summary and Discussion
Catherine Meyers and Jay Hoofnagle
Report published as Hepatitis and Renal Disease: An Update, American Journal of Kidney Disease, October 2003; Vol. 42: No. 4.
Up To Top
Page last updated: November 05, 2010
